检索历史清除

首页> Cancer research: The official organ of the American Association for Cancer Research, Inc> Lorlatinib Treatment Elicits Multiple On- and Off-Target Mechanisms of Resistance in ALK-Driven Cancer

Lorlatinib Treatment Elicits Multiple On- and Off-Target Mechanisms of Resistance in ALK-Driven Cancer

导出原文传递

翻译打印收藏纠错

作者： Redaelli, Sara ^[1] ; Ceccon, Monica ^[2] ; Zappa, Marina ; Sharma, Geeta G. ; Mastini, Cristina ; Mauri, Mario ; Nigoghossian, Marion ; Massimino, Luca ; Cordani, Nicoletta ; Farina, Francesca ; Piazza, Rocco ; Gambacorti-Passerini, Carlo ; Mologni, Luca

作者单位： San Gerardo Hosp, Hematol & Clin Res Unit, Monza, Italy ^[1] Univ Milano Bicocca, Sch Med & Surg, Via Cadore 48, I-20900 Monza, Italy ^[2]

发布时间 2019-04-18

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交